SIOUX CENTER, Iowa, April 27, 2016 /PRNewswire/ -- Exemplar Genetics, committed to enabling the study of life-threatening human diseases,
today announced the U.S. Food & Drug Administration (FDA) has
exercised enforcement discretion in regard to the ExeGen® low-density lipoprotein receptor (LDLR) miniswine clearing it for commercial use as a research model.
[Link deleted in the interests of good taste]
Biotech researchers have already obsoleted our two leading candidates for president as well as many retired military commanders as model subjects for medical research.
Can it yet be so much more difficult for photonics engineers to figure out how to let the light shine?
Best, Terry